<DOC>
	<DOCNO>NCT02614781</DOCNO>
	<brief_summary>This study non-interventional prospective , multicenter , longitudinal study conduct France , among representative sample public and/or private birth control center . The aim study ass , real-life setting , success rate protocol Mifegyne / prostaglandin analogue patient ask medical abortion either prior beyond 7 week amenorrhea .</brief_summary>
	<brief_title>Efficacy Mifepristone - Prostaglandin Analogue Combination Medical Termination Pregnancy Beyond 7 Weeks Amenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Adult woman ( â‰¥ 18 year old ) confirm intrauterine pregnancy consult medical termination pregnancy Patients physician decides use Mifegyne 600 mg prostaglandin analogue combination medical abortion Patients agree participate study inform orally physician give information sheet Informed patient accept computer process medical data right access correction Patients know hypersensitivity mifepristone Patients know hypersensitivity prostaglandin analogue ( misoprostol gemeprost ) . Patients severe progressive disease Patients ectopic pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>